In June 2018, Phase Holographic Imaging (PHI) and BioSpherix Medical entered a collaboration agreement, aiming to co-market the companies’ complementary product lines. BioSpherix develops and markets advanced hermetically sealed cell incubators for the control and optimization of cell culture environments. Since most cell analysis instruments are not adapted to cope with the demanding environment within cell incubators,

To read the full story...

Already a subscriber? Login now

< | >